A Phase 3 interventional study of Stannous Fluoride and Sodium Monofluorophosphate in Dentine Hypersensitivity, sponsored by GlaxoSmithKline. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-03-10.
Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Dentin Sensitivity by GlaxoSmithKline — none open to participants now, none under way, none of them phase 3. Dentin Sensitivity · GlaxoSmithKline.
Among the 28 studies in Dentin Sensitivity by GlaxoSmithKline, this one is the 20th largest by enrollment, is one of 4 that started in 2012, is one of 5 in phase 3, and was the 3rd registered.
290 studies on the registry are indexed under Dentin Sensitivity; 48 are open to participants now.
Browse Dentin Sensitivity studies →None of the 28 studies in Dentin Sensitivity by GlaxoSmithKline is open now. The open studies under Dentin Sensitivity, anywhere →
Of the 19 Dentin Sensitivity studies recruiting now, 6 (32%) set no upper age limit and 12 (63%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 4 started in 2012.
This study's enrollment of 120 is above the median of 60 across 281 interventional studies indexed under Dentin Sensitivity.
Median enrollment 164 across the 28 interventional studies. Of the 27 that completed or were terminated, 27 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 117 are open to participants now.
Of its 265 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 28 studies in Dentin Sensitivity by GlaxoSmithKline, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A study to compare the efficacy of a test dentifrice against a control dentifrice in reducing dentinal hypersensitivity over an eight week treatment period.
Inclusion Criteria:
Inclusion Criteria:
Dentifrice containing stannous fluoride
Drug: Stannous Fluoride
Marketed dentifrice containing Sodium Monofluorophosphate
Drug: Sodium Monofluorophosphate
dentifice
dentifrice
Mean Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Week 8
Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus.
Time frame: Baseline to 8 weeks post administration of study treatment
Mean Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Week 4
Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus.
Time frame: Baseline to 4 weeks post administration of study treatment
Adjusted Mean Change From Baseline in Tactile Sensitivity Pain Response at Week 8
Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale. The constant pressure probe allowed the examiner to vary the force applied to the dentin surface from 10 grams (g) to an upper threshold of 80 g, in increments of 10g since the values below represents adjusted mean change in baseline, the value can fall below scale range. The greater the pressure the subject was able to tolerate, the less. Change from baseline in tactile response to Week 8 was calculated. sensitive the tooth. According to this tactile sensitivity assessment, an increasing force was applied to hypersensitive tooth until a yes response is recorded or the maximum force has been reached.
Time frame: Baseline to 8 weeks post administration of study treatment
Adjusted Mean Change From Baseline in Tactile Sensitivity Pain Response at Week 4
Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale. The constant pressure probe allowed the examiner to vary the force applied to the dentin surface from 10g to an upper threshold of 80g, in increments of 10g. The greater the pressure the subject was able to tolerate, the less sensitive the tooth. According to this tactile sensitivity assessment, an increasing force was applied to hypersensitive tooth until a yes response is recorded or the maximum force has been reached. Change from baseline in tactile response to Week 4 was calculated
Time frame: Baseline to 4 weeks post administration of study treatment
Participants were recruited at the clinical site.
| Milestone | Stannous Fluoride (SnF) Dentifrice | Sodium Monofluorophosphate (NaMFP) Dentifrice |
|---|---|---|
| Started | 60 | 58 |
| Completed | 60 | 57 |
| Not completed | 0 | 1 |
| Withdrew: Withdrawal by subject | 0 | 1 |
Response to a constant jet of air applied to hypersensitive teeth is evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus.
| Score on a scale | SnF Dentifrice | NaMFP Dentifrice |
|---|---|---|
| Mean Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Week 8 | -0.9 ± 0.68 | -0.5 ± 0.44 |
Response to a constant jet of air applied to hypersensitive teeth was evaluated using a Schiff Sensitivity pain response scale. According to this analog scale, pain response for each individual stimulated tooth ranged from 0 to 3; 0 - participant does not respond to air stimulation, 1 - participant responds to air stimulus but does not request discontinuation of stimulus, 2 - participant responds to air stimulus and request discontinuation of stimulus, 3 - participant responds to air stimulus, considers stimulus to be painful and request discontinuation of stimulus.
| Score on a scale | SnF Dentifrice | NaMFP Dentifrice |
|---|---|---|
| Mean Change From Baseline in Evaporative Air Sensitivity Pain Response on a Schiff Sensitivity Scale at Week 4 | -0.7 ± 0.58 | -0.2 ± 0.43 |
Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale. The constant pressure probe allowed the examiner to vary the force applied to the dentin surface from 10 grams (g) to an upper threshold of 80 g, in increments of 10g since the values below represents adjusted mean change in baseline, the value can fall below scale range. The greater the pressure the subject was able to tolerate, the less. Change from baseline in tactile response to Week 8 was calculated. sensitive the tooth. According to this tactile sensitivity assessment, an increasing force was applied to hypersensitive tooth until a yes response is recorded or the maximum force has been reached.
| grams | SnF Dentifrice | NaMFP Dentifrice |
|---|---|---|
| Adjusted Mean Change From Baseline in Tactile Sensitivity Pain Response at Week 8 | 21.3 ± 21.80 | 4.2 ± 6.18 |
Response to increasing force on hypersensitive teeth was evaluated using a Yeaple Probe pain response scale. The constant pressure probe allowed the examiner to vary the force applied to the dentin surface from 10g to an upper threshold of 80g, in increments of 10g. The greater the pressure the subject was able to tolerate, the less sensitive the tooth. According to this tactile sensitivity assessment, an increasing force was applied to hypersensitive tooth until a yes response is recorded or the maximum force has been reached. Change from baseline in tactile response to Week 4 was calculated
| grams | SnF Dentifrice | NaMFP Dentifrice |
|---|---|---|
| Adjusted Mean Change From Baseline in Tactile Sensitivity Pain Response at Week 4 | 11.2 ± 15.95 | 1.5 ± 3.86 |
Collected over All adverse events encountered or spontaneously reported following administration of any investigational product, or for up to 5 days after the last administration of investigational product were recorded.. Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| SnF Dentifrice | — | 0/60 (0%) | 1/60 (1.7%) |
| NaMFP Dentifrice | — | 1/58 (1.7%) | 0/58 (0%) |
| Event | SnF Dentifrice | NaMFP Dentifrice |
|---|---|---|
| CholecystitisHepatobiliary disorders | 0/60 | 1/58 |
| Event | SnF Dentifrice | NaMFP Dentifrice |
|---|---|---|
| Oral HerpesInfections and infestations | 1/60 | 0/58 |
| Age, Continuous(Years) | SnF Dentifrice | NaMFP Dentifrice | Total |
|---|---|---|---|
| Mean | 36.9 ± 10.9 | 35.5 ± 10.6 | 36.2 ± 10.7 |
| Sex: Female, Male(Participants) | SnF Dentifrice | NaMFP Dentifrice | Total |
|---|---|---|---|
| Female | 46 | 37 | 83 |
| Male | 14 | 21 | 35 |
The record gives a start of Mar 2012, a primary completion of May 2012 and a completion of May 2012. It does not say whether these dates are actual or estimated.
Results were first posted in Mar 2014, 1 year 10 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tin Fluorides